Experimental Hematology
Volume 38, Issue 5 , Pages 384-391, May 2010

F104S c-Mpl responds to a transmembrane domain−binding thrombopoietin receptor agonist: Proof of concept that selected receptor mutations in congenital amegakaryocytic thrombocytopenia can be stimulated with alternative thrombopoietic agents

  • Norma E. Fox

      Affiliations

    • Drs. Fox and Lim contributed equally to this work.
    • ,
  • Jihyang Lim

      Affiliations

    • Drs. Fox and Lim contributed equally to this work.
    • ,
  • Rose Chen
    • ,
  • Amy E. Geddis

      Affiliations

    • Corresponding Author InformationOffprint requests to: Amy E. Geddis, M.D., Ph.D., Pediatric Hematology-Oncology, University of California, San Diego, 9500 Gilman Drive, Mailcode 0671, La Jolla, CA 92017

Pediatric Hematology-Oncology, University of California, San Diego, La Jolla, Calif., USA

Received 30 September 2009; received in revised form 10 February 2010; accepted 16 February 2010. published online 25 February 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0301-472X(10)00052-4

doi:10.1016/j.exphem.2010.02.007

Experimental Hematology
Volume 38, Issue 5 , Pages 384-391, May 2010

Article Tools

* Image Usage & Resolution